Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
IKang Healthcare Group (ADR) (KANG US)
Watchlist
62
Analysis
Health Care
•
China
iKang Healthcare Group, Inc is a corporate preventative healthcare provider. The Company provides medical examination, screening and other services. iKang focuses in mainland China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
09 Jul 2015 06:01
Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
Kemp Dolliver, CFA
577 Views
Share
bearish
•
Thematic (Sector/Industry)
•
01 Jul 2015 22:01
China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
Kemp Dolliver, CFA
605 Views
Share
bullish
•
Thematic (Sector/Industry)
•
21 Feb 2015 00:02
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
Kemp Dolliver, CFA
602 Views
Share
bullish
•
Dada Nexus
•
01 Apr 2025 21:29
Dada Nexus (DADA US): JD.com’s Binding Offer a Done Deal
Although the offer is unattractive, this is a done deal. The transaction is expected to close within the third quarter of 2025.
Arun George
Follow
699 Views
Share
bullish
•
PropertyGuru
•
23 May 2024 00:41
PropertyGuru (PGRU US): KKR/TPG Mulling a Buyout
The concentrated shareholder register would suggest that TPG/KKR would aim for irrevocable from the other three substantial shareholders,...
Arun George
Follow
663 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x